Search results (808)
« Back to NewsNew study estimates NHS England spends 3% of its primary and secondary care budget on the health impacts of temperature
24 December 2025
A new University of Oxford-led study, published in The Lancet Planetary Health, is the first to link daily temperature data to health-care use and costs across primary and secondary care in England. Analysis of 4.37 million patient records in England has found resources asymmetrically impacted by winter cold and summer heat, with about 64% linked to common cold days while very hot days drive sharp same-day demand surges.
Driving the development of new tools to combat Nipah virus outbreaks
18 December 2025
PSI’s Nipah Virus Research Day showcased promising developments, spanning new insights into Nipah virus biology, clinical trials of vaccines, the development of policy responses, and progress in developing diagnostics and treatments, which are helping improve responses to outbreaks of this deadly virus.
Kennedy researchers contribute to UK-wide AI and bioscience training initiative
18 December 2025
Together with a group of Oxford researchers, Mark Coles, Professor of Immunology at the Kennedy Institute, will co-lead the Enabling Next-generation AI for a Bioscience-Led Economy (ENAIBLE) initiative.
New study offers breakthrough in detecting risk for psychosis and bipolar disorders
16 December 2025
A study published recently in The Lancet Psychiatry has unveiled a new approach to identifying individuals at risk of developing psychotic disorders or bipolar disorder.
International collaboration launches largest-ever therapeutics trial for patients hospitalised with dengue
16 December 2025
A landmark international research collaboration has launched the largest clinical trial ever conducted to test therapeutics for moderate-severe dengue, a mosquito-borne viral disease that continues to spread rapidly driven by climate change and globalisation.
Oxford University and Brazil Ministry of Health Sign Letter of Intent to Strengthen Cancer Care Across Brazil
15 December 2025
The Ministry of Health of Brazil and Oxford’s Centre for Immuno-Oncology, part of the Nuffield Department of Medicine, have signed a Letter of Intent establishing a broad collaboration to advance cancer research, innovation and clinical translation. The agreement builds on the UK-Brazil Government Health Partnership signed earlier this year, and reflects a shared commitment to accelerating research that will lead to improvements in cancer care across Brazil.
Oxford cancer researchers welcome UK AI for Science Strategy, highlighting the opportunity for national AI-ready cancer data
11 December 2025
Oxford researchers have welcomed the UK government’s new AI for Science Strategy, which sets out an ambitious plan to harness artificial intelligence, sovereign supercomputing and high-quality scientific data to accelerate discovery in the life sciences.
Cognitive impairment after a stroke calls for tailored recovery treatment shows new study
11 December 2025
A major new study recently published in Imaging Neuroscience shows that the brain location of the stroke does not always determine the symptoms.
Simple scoring system could help clinicians identify possible cases of NMDAR-antibody encephalitis
11 December 2025
Scientists from across Oxford have identified a key set of symptoms and developed a scoring system to help clinicians in frontline medical and mental health services consider the possibility of a rare form of encephalitis, which can sometimes be mistaken for psychosis.
New research collaboration to tackle ethnic inequalities in perinatal severe mental illness
10 December 2025
A ground-breaking new study aims to transform postpartum mental health care for mothers from ethnic minority backgrounds or those living in deprived areas who experience severe mental illness.
Oxford researchers develop first live-cell assay linking cancer tumour metabolism to drug effectiveness
10 December 2025
Scientists at the Centre for Medicines Discovery, part of Oxford University’s Nuffield Department of Medicine, have developed a biosensor that, for the first time, allows researchers to directly measure how experimental cancer drugs engage their target inside living cells dependent on co-factors and metabolites.
World-leading researchers unite for ‘pivotal’ study to help children and adults with arthritis to live drug free
10 December 2025
The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration which includes world-leading researchers from the Kennedy Institute.
Expert Comment: The world’s most important antibiotic has become our greatest challenge
10 December 2025
Today, on the 80-year anniversary of the Nobel Prize being awarded for the discovery and development of penicillin, Dr Alistair Farley, Scientific Lead at the Ineos Oxford Institute for antimicrobial research (IOI), urges that the collaboration behind this achievement is channelled again today to address one of the greatest global medical challenges of our time.
Blood test predicts risk of death in acutely ill children in lower-income countries
9 December 2025
An international study has identified a blood-based indicator of intestinal damage and inflammation that strongly predicts mortality in sick children. The new biomarker could help to identify those children at greatest risk of dying after hospitalisation in parts of the world with limited resources.
Addressing antimicrobial resistance through advanced UTI models
9 December 2025
A collaborative study, which includes contributions from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) researchers Aaron Crowther and supervisor Dario Carugo, explores new ways to model bladder biology and infection, allowing evaluation of antimicrobial therapies under physiologically relevant conditions.
World's first Phase II Nipah virus vaccine trial launch
9 December 2025
The University of Oxford has launched the world’s first Phase II clinical trial of a Nipah virus vaccine candidate.
European Research Council (ERC) Consolidator Grants awarded to eleven Oxford academics
9 December 2025
Eleven academics from the University of Oxford are to lead new research projects supported by European Research Council (ERC) Consolidator Grants. These grants support highly promising mid-career scientists of any nationality and any field with building a research team at an eligible host organisation.
First volunteer receives Lassa Fever vaccine in cutting-edge Oxford trial
8 December 2025
The first volunteer has received a dose in a first-in-human trial of Oxford’s Lassa vaccine, marking a major milestone in the fight against the deadly virus.
Rapid, low-cost tests can help prevent child deaths from contaminated medicinal syrups
4 December 2025
Researchers at the University of Oxford and their collaborators have demonstrated that simple, rapid, and inexpensive tests can detect deadly contaminants in medicinal syrups - contaminants that have tragically led to the deaths of hundreds of children worldwide.
Study gives insight into mental health and wellbeing of thousands of teenagers
4 December 2025
A pilot study of more than 15,000 teenagers gives a complex picture of adolescent mental health, finding associations between wellbeing and factors such as sleep, vaping and exercise.